GB0921686D0 - Topical formulation - Google Patents

Topical formulation

Info

Publication number
GB0921686D0
GB0921686D0 GBGB0921686.2A GB0921686A GB0921686D0 GB 0921686 D0 GB0921686 D0 GB 0921686D0 GB 0921686 A GB0921686 A GB 0921686A GB 0921686 D0 GB0921686 D0 GB 0921686D0
Authority
GB
United Kingdom
Prior art keywords
topical formulation
topical
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0921686.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare International Ltd
Original Assignee
Reckitt Benckiser Healthcare International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare International Ltd filed Critical Reckitt Benckiser Healthcare International Ltd
Priority to GBGB0921686.2A priority Critical patent/GB0921686D0/en
Publication of GB0921686D0 publication Critical patent/GB0921686D0/en
Priority to PCT/GB2010/002240 priority patent/WO2011070318A2/en
Priority to GB1020601A priority patent/GB2476155A/en
Priority to TW099143214A priority patent/TW201129396A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0921686.2A 2009-12-11 2009-12-11 Topical formulation Ceased GB0921686D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0921686.2A GB0921686D0 (en) 2009-12-11 2009-12-11 Topical formulation
PCT/GB2010/002240 WO2011070318A2 (en) 2009-12-11 2010-12-06 Topical formulation
GB1020601A GB2476155A (en) 2009-12-11 2010-12-06 Topical NSAID formulations
TW099143214A TW201129396A (en) 2009-12-11 2010-12-10 Topical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921686.2A GB0921686D0 (en) 2009-12-11 2009-12-11 Topical formulation

Publications (1)

Publication Number Publication Date
GB0921686D0 true GB0921686D0 (en) 2010-01-27

Family

ID=41666943

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0921686.2A Ceased GB0921686D0 (en) 2009-12-11 2009-12-11 Topical formulation
GB1020601A Withdrawn GB2476155A (en) 2009-12-11 2010-12-06 Topical NSAID formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1020601A Withdrawn GB2476155A (en) 2009-12-11 2010-12-06 Topical NSAID formulations

Country Status (3)

Country Link
GB (2) GB0921686D0 (en)
TW (1) TW201129396A (en)
WO (1) WO2011070318A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20180399A1 (en) 2011-05-03 2018-02-28 Aponia Laboratories Inc TRANSDERMAL COMPOSITIONS OF IBUPROFEN AND METHODS OF USE OF THE SAME
JP6893086B2 (en) 2013-03-13 2021-06-23 エーブリー デニソン コーポレイション Improved adhesive properties
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
GB201502845D0 (en) * 2015-02-20 2015-04-08 Futura Medical Dev Ltd Topical pharmaceutical formulation
GB201503590D0 (en) * 2015-03-03 2015-04-15 Davis Adrian Topical formulation
GB201609968D0 (en) * 2016-06-07 2016-07-20 Futura Medical Dev Ltd Topical pharmaceutical formulation
FR3108841B1 (en) 2020-04-06 2023-11-03 Algotherapeutix TOPICAL PHARMACEUTICAL COMPOSITION IN AQUEOUS GEL FORM COMPRISING AT LEAST AMITRIPTYLINE
EP4188325A1 (en) 2020-07-27 2023-06-07 Incanthera R&D Ltd. Topical formulation
GB2597526A (en) 2020-07-27 2022-02-02 Incanthera R&D Ltd Topical formulation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments
CH655656B (en) * 1982-10-07 1986-05-15
DE3532562A1 (en) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg TRANSDERMALLY RESORBABLE, WATER-BASED PREPARATIONS OF ARYLPROPIONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
CN1106259A (en) * 1994-02-05 1995-08-09 日东制药株式会社 Antiphlogistic and analgesic gel agent for external use containing propanoic acid non steroid pharmaceutical as effective composition
US6054484A (en) * 1996-02-07 2000-04-25 Tsumura & Co. Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same
US6083996A (en) * 1997-11-05 2000-07-04 Nexmed Holdings, Inc. Topical compositions for NSAI drug delivery
ATE356636T1 (en) 2000-08-03 2007-04-15 Antares Pharma Ipl Ag COMPOSITION FOR TRANSDERMAL AND/OR TRANSMUCOSAL ADMINISTRATION OF ACTIVE INGREDIENTS WHICH GUARANTEES ADEQUATE THERAPEUTIC LEVELS
JP2003095983A (en) * 2001-09-21 2003-04-03 Lion Corp Skin external preparation composition
DE602007002154D1 (en) * 2007-03-02 2009-10-08 Flamek Corp Oue Analgesic composition of topically applied, non-steroidal and anti-inflammatory drugs and opioids
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US20090246273A1 (en) * 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Ketorolac Sublingual Spray for the Treatment of Pain

Also Published As

Publication number Publication date
GB201020601D0 (en) 2011-01-19
TW201129396A (en) 2011-09-01
WO2011070318A3 (en) 2011-10-20
WO2011070318A2 (en) 2011-06-16
GB2476155A (en) 2011-06-15

Similar Documents

Publication Publication Date Title
GB0913255D0 (en) Topical composition
GB2474930B (en) Topical tetracycline compositions
ZA201105769B (en) Topical foam composition
IL218865A0 (en) Topical tetracycline compositions
IL214615A0 (en) Anti-fungal formulation
GB201020601D0 (en) Topical formulation
ZA201204018B (en) Topical foam composition
EP2645983A4 (en) Melanin promoting topical composition
GB0912239D0 (en) Cosmetic formulation
GB0907003D0 (en) Formulation
GB201010256D0 (en) Germicidal topical compositions
ZA201204017B (en) Topical foam composition
GB0822633D0 (en) Formulation
GB201021836D0 (en) Topical Composition
WO2010114629A9 (en) Formulation
GB0800788D0 (en) Niovel formulation
GB0808479D0 (en) Topical compositions
EP2124938A4 (en) Topical formulation
GB201010029D0 (en) Topical germicidal compositions
GB0814376D0 (en) Formulation
IL221333A0 (en) Topical antibiotic formulations
GB201300858D0 (en) Topical Composition
IL197464A0 (en) Foamable topical composition
GB0911213D0 (en) Formulation
GB0907410D0 (en) Formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)